Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel rejects AZ's new RSV drug in key setback
FDA panel rejects AZ's new RSV drug in key setback
FDA panel rejects AZ's new RSV drug in key setback
Submitted by
admin
on June 3, 2010 - 10:07am
Source:
Fierce Biotech
News Tags:
RSV
motavizumab
MedImmune
FDA
AstraZeneca
Headline:
FDA panel rejects AZ's new RSV drug in key setback
Do Not Allow Advertisers to Use My Personal information
